Introduction 140
Fundamental for all facets of multicellular life and evolutionarily conserved, the extracellular matrix 141 (ECM) is a diverse network of instructional cues linking the local tissue microenvironment with the 142 juxtaposed tumor cells [1] [2] [3] . Emerging as a critical entity in chemotherapeutics, tumorigenic 143 progression, and predicting clinical outcome [4] [5] [6] , the ECM is a nexus of signal integration for a 144 plethora of cell-derived factors while synchronously regulating cellular behaviors [7] . This symbiotic 145 relationship facilitates bidirectional parsing of intrinsic biological information into functionally relevant 146 processes responsible for orchestrating tumorigenesis and angiogenesis [8] [9] [10] . 147
The small leucine-rich proteoglycans (SLRPs) are an emerging subset of matrix-derived, soluble 148 Importantly, the covalently attached glycosaminoglycan chain plays a pivotal role in the regulation 278 of collagen fibrillogenesis [15] . However, in the context of controlling intracellular signaling cascades 279 via cell surface receptors, the glycosaminoglycan chain is dispensable. 280
The glycosaminoglycan chain has a pivotal role in various connective tissue disorders insofar as 281 alterations in the chain are found in congenital stromal corneal dystrophy and Ehlers-Danlos 282 syndrome [100] as well as in cancer [12] . Improperly modified or missing chains can disrupt structural 283 functions as mediated by decorin by compromising the architecture of the surrounding matrix. This is 284 exemplified in the skin fragility phenotype of patients with Ehlers-Danlos syndrome, where roughly half 285 of the secreted decorin lacks the chain [101] . Mechanistically, early stages of collagen fibril formation 286 are impaired following the loss of the glycosaminoglycan chain. Moreover, the type and composition 287 of the attached glycosaminoglycan can also vary, particularly in cancer (colon, ovarian, pancreatic, 288 gastric), where it is predominantly chondroitin sulfate [10, 12, 72, 102] . In contrast, the chemically more 289 complex dermatan sulfate is less abundant in these types of tumors [102] . The presence of CS is 290 postulated to facilitate cell migration, thereby increasing the malignancy of the tumor [102] . 291 292
Decorin is a soluble pan-RTK inhibitor and binds multiple cell surface receptors 293
As discussed above (section 2.1), the overall arrangement of decorin, in conjunction with the 294 individual composition of the LRRs, endows a rather promiscuous nature of binding multiple targets 295 expressed within the tumor microenvironment and by the tumor proper. Of critical importance for 296 attenuating tumorigenic progression and preventing metastases, decorin avidly binds numerous cell 297 surface receptors [95] (Fig. 1B) . Decorin can be considered an endogenous, soluble pan-RTK 298 inhibitor, especially targeting cells enriched in EGFR, Met, and VEGFR2. These three RTKs are the 299 most established and instrumental for transducing signals necessary for oncogenic and angiogenic 300 suppression [31, 54] (Fig. 1B) . As such, this trio of receptors will be discussed in more depth in the 301 forthcoming sections (see below, sections 3 and 4). 302
Decorin, non-canonically, engages IGF-IR (Fig. 1B) degradation. This system prevents recycling of EGFR for additional rounds of signaling, in contrast to 372 active ligands which sort EGFR into clathrin-coated pits. This leads to endosomal recycling and, 373 ultimately, to repopulation of the cell surface with activated EGFR for additional signal transduction 374 (Fig. 2) . 375 as being independent from Axin/DSH/GSK-3activity [89] . In this scenario, -catenin is 395 phosphorylated, not for increased protein stability, and is instead targeted for degradation [125] (Fig. 3, left) (Fig. 3, left) (Fig. 3, left) . Concomitant with autophagic initiation, decorin also impairs 465 capillary morphogenesis [78, 79, 159] . Therefore, it is plausible that decorin evokes autophagy as the 466 molecular underpinning for suppressing tumor angiogenesis from the perspective of endothelial cell-467 driven angiogenesis (Fig. 3, left) . 468 469
Decorin induces tumor cell mitophagy in a mitostatin-dependent manner 470
As a novel constituent of the multi-pronged approach for curtailing tumorigenesis and halting 471 angiogenesis (differential modulation of pro-and anti-angiogenic factors and induction of endothelial 472 cell autophagy) decorin directly influences catabolic programs and organelle turnover within the tumor 473 proper (Fig.3, right) . Induction of tumor cell mitochondrial autophagy (mitophagy) [165] may 474 functionally reconcile the canonical tumoricidal effects of decorin with the emerging biology of matrix-475 mediated autophagic induction for retarding tumorigenic and angiogenic progression. In a mechanism 476 analogous to that of VEGFR2, decorin requires the kinase activity of Met for proper mitophagic 477 induction in breast carcinoma cells [165] (Fig. 3, right) (Fig. 3, right) . The process of decorin-evoked mitophagy depends on the presence and yet-to-be-elucidated-499 function of mitostatin [165] (Fig. 3, right) . RNAi-mediated silencing of mitostatin prevents turnover of 500 respiratory chain components (OXPHOS), decreased mtDNA content, VDAC clearance, and collapse 501 of the mitochondrial network [165] , all established markers of mitophagy [172] . Moreover, failure of 502 mitophagic induction precludes the ability of decorin in suppressing VEGFA expression and protein 503
[165] (Fig. 3, right) , suggesting that mitophagy is key for understanding a fundamental hallmark of 504 decorin biology. Subsequent to the collapse and aggregation of the tubular mitochondrial network, 505 decorin triggers mitochondrial depolarization [165] , with an activity comparable to that of an 506 established depolarization agent (FCCP). This loss of membrane potential across the outer and inner 507 mitochondrial membrane is a harbinger for mitochondrial dysfunction and eventual turnover [173, 174] . 508
Depolarized mitochondria may be the end product of increased Ca +2 levels as occur downstream from 509 decorin/EGFR interactions [123] . As mitostatin is positioned at mitochondrial-associated membrane 510 and interacts with Mfn-2, it may permit an efflux of Ca +2 from the ER directly into the mitochondria as 511 the initial event for decorin-evoked mitophagy. interact with or facilitate the conscription of PINK1/Parkin for mitochondrial turnover (Fig. 3, right) . proteoglycan or protein core, has been tested in a variety of preclinical studies. In Table 1 we 531 summarize past and current studies utilizing these two approaches focused exclusively on cancer 532 treatment and delivery. Although the therapeutic efficacy varies among these studies, it is clear that 533 decorin has a deleterious effect on growth, apoptosis, metabolism and angiogenesis. 534 
